Samalin Investment Counsel, LLC Amgen Inc Transaction History

Samalin Investment Counsel, LLC

$207 Million
Q2 2024

A detailed history of Samalin Investment Counsel, LLC transactions in Amgen Inc stock. As of the latest transaction made, Samalin Investment Counsel, LLC holds 2,140 shares of AMGN stock, worth $684,222. This represents 0.32% of its overall portfolio holdings.

Number of Shares

2,140

Previous 1,986 7.75%

Holding current value

$684,222

Previous $564,000 18.44%

% of portfolio

0.32%

Previous 0.28%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $40,463 - $49,173	154 Added 7.75%	2,140 $668,000
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $83,349 - $100,613	-310 Reduced 13.5%	1,986 $564,000
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $8,949 - $10,096	-35 Reduced 1.5%	2,296 $661,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $37,607 - $46,691	172 Added 7.97%	2,331 $626,000
Q2 2023 Aug 03, 2023	BUY	$214.27 - $253.37 $139,918 - $165,450	653 Added 43.36%	2,159 $479,000
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $4,515 - $5,504	20 Added 1.35%	1,506 $364,000
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $37,789 - $48,016	-165 Reduced 9.99%	1,486 $390,000
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $56,788 - $64,046	253 Added 18.1%	1,651 $372,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $10,843 - $12,066	47 Added 3.48%	1,398 $340,000
Q1 2022 Oct 13, 2022	BUY	$219.27 - $242.57 $91,874 - $101,636	419 Added 44.96%	1,351 $327,000
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $91,874 - $101,636	419 Added 44.96%	1,351 $327 Million
Q4 2021 Oct 13, 2022	BUY	$198.88 - $227.6 $9,745 - $11,152	49 Added 5.55%	932 $210,000
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $9,148 - $10,469	46 Added 5.19%	932 $210 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $636 - $746	3 Added 0.34%	886 $188 Million
Q2 2021 Oct 13, 2022	BUY	$233.58 - $259.14 $6,773 - $7,515	29 Added 3.4%	883 $215,000
Q2 2021 Aug 12, 2021	BUY	$233.58 - $259.14 $4,671 - $5,182	20 Added 2.32%	883 $215,000
Q1 2021 May 11, 2021	BUY	$221.91 - $258.6 $11,983 - $13,964	54 Added 6.67%	863 $214,000
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $9,737 - $11,595	-45 Reduced 5.27%	809 $186 Million
Q3 2020 Oct 13, 2022	SELL	$234.65 - $260.95 $127,649 - $141,956	-544 Reduced 38.91%	854 $217,000
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $11,497 - $12,786	-49 Reduced 5.43%	854 $217,000
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $178,622 - $219,194	903 New	903 $213,000
Q1 2020 May 04, 2020	SELL	$182.24 - $241.7 $167,114 - $221,638	-917 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$189.21 - $243.2 $173,505 - $223,014	917 New	917 $221,000

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samalin Investment Counsel, LLC with notifications on news.

Account

Samalin Investment Counsel, LLC Amgen Inc Transaction History